ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Gastroenterology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,719Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 187

$1.05M Total Retail Price of All Prescriptions

Rank: 2 out of 187

425 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

10% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 15,630 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 40%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $146 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 6.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 860 741 1 12
FUROSEMIDE 658 600 2 11
OMEPRAZOLE 551 455 3 1
LEVOTHYROXINE SODIUM 551 504 3 9
AMLODIPINE BESYLATE 513 488 5 8
SIMVASTATIN 414 349 6 6
DONEPEZIL HCL 396 355 7 19
SERTRALINE HCL 381 361 8 32
METOPROLOL TARTRATE 374 348 9 17
TRAZODONE HCL 347 302 10 31
LISINOPRIL 327 312 11 13
POTASSIUM CHLORIDE 285 259 12 27
MIRTAZAPINE 282 253 13 26
RISPERIDONE 251 222 14 40
QUETIAPINE FUMARATE 217 175 15 55
CYMBALTA 202 186 16 53
LANTUS 193 180 17 52
NAMENDA 193 168 17 35
CITALOPRAM HBR 191 178 19 39
METFORMIN HCL 189 169 20 22
METOPROLOL SUCCINATE 177 165 21 24
PRAVASTATIN SODIUM 173 173 22 37
ESCITALOPRAM OXALATE 170 149 23 30
ALLOPURINOL 166 154 24 54
ISOSORBIDE MONONITRATE ER 161 156 25 61
RANITIDINE HCL 158 129 26 5
GABAPENTIN 152 120 27 47
ATORVASTATIN CALCIUM 150 136 28 14
PREDNISONE 149 139 29 49
OXYBUTYNIN CHLORIDE ER 148 123 30 63
ATENOLOL 143 124 31 29
SPIRONOLACTONE 142 117 32 57
LIDODERM 140 130 33 79
HYDROCODONE-ACETAMINOPHEN 138 119 S3 34 43
FAMOTIDINE 132 130 35 20
FENTANYL 129 129 S2 36 60
NOVOLIN R 124 124 37 86
ADVAIR DISKUS 121 115 38 58
DIVALPROEX SODIUM 119 109 39 89
NYSTATIN 109 89 40 71
ABILIFY 108 106 41 74
ALENDRONATE SODIUM 108 99 41 41
BENZTROPINE MESYLATE 107 69 R 43 94
BACLOFEN 107 49 43 94
DIOVAN 105 105 45 48
RAMIPRIL 104 87 46 73
CARBIDOPA-LEVODOPA 103 95 47 50
TAMSULOSIN HCL 103 90 47 51
GENERLAC 100 83 49 96
OLANZAPINE 96 78 50 97
PANTOPRAZOLE SODIUM 94 87 51 3
EXELON 93 93 52 70
ZOLPIDEM TARTRATE 92 66 53 34
CLOPIDOGREL 91 87 54 56
HYDROCHLOROTHIAZIDE 91 91 54 23
GLIPIZIDE 90 90 56 59
IPRATROPIUM-ALBUTEROL 85 77 57 69
METOLAZONE 84 72 58 101
DIVALPROEX SODIUM ER 79 47 59 104
ACETAMINOPHEN-CODEINE 78 76 S3 60 105
SPIRIVA 77 68 61 64
LEVETIRACETAM 75 58 62 107
CARVEDILOL 75 69 62 68
SEROQUEL 74 52 64 85
ZETIA 72 72 65 66
FINASTERIDE 70 58 66 113
NEXIUM 69 57 67 2
METHENAMINE HIPPURATE 69 50 67 114
POLYETHYLENE GLYCOL 3350 68 59 69 7
FENOFIBRATE 66 53 70 120
DILTIAZEM 24HR CD 66 66 70 78
HYDRALAZINE HCL 66 66 70 120
CEPHALEXIN 66 60 70 120
GLIMEPIRIDE 66 66 70 81
CHLORTHALIDONE 65 54 75 123
LOSARTAN POTASSIUM 63 63 76 67
OXYCODONE HCL 62 47 S2 77 125
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 51 78 128
OXYCODONE-ACETAMINOPHEN 58 58 S2 79 76
NOVOLOG 53 51 80 88
PAROXETINE HCL 52 50 81 82
LUMIGAN 51 51 82 142
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 51 82 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.